These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19010974)

  • 41. Aripiprazole in the treatment of bipolar disorder in children and adolescents.
    Durkin JP
    J Child Adolesc Psychopharmacol; 2004; 14(4):505-6. PubMed ID: 15662141
    [No Abstract]   [Full Text] [Related]  

  • 42. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study.
    Young AH; Oren DA; Lowy A; McQuade RD; Marcus RN; Carson WH; Spiller NH; Torbeyns AF; Sanchez R
    Br J Psychiatry; 2009 Jan; 194(1):40-8. PubMed ID: 19118324
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review.
    Biederman J; McDonnell MA; Wozniak J; Spencer T; Aleardi M; Falzone R; Mick E
    CNS Spectr; 2005 Feb; 10(2):141-8. PubMed ID: 15685125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
    Mankoski R; Zhao J; Carson WH; Mathew SJ; Forbes RA
    J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):359-64. PubMed ID: 21823911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aripiprazole: an overview of a novel antipsychotic.
    Uzun S; Kozumplik O; Mimica N; Folnegović-Smalc V
    Psychiatr Danub; 2005 Jun; 17(1-2):67-75. PubMed ID: 16395846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aripiprazole in the treatment of Alzheimer's disease.
    De Deyn PP; Drenth AF; Kremer BP; Oude Voshaar RC; Van Dam D
    Expert Opin Pharmacother; 2013 Mar; 14(4):459-74. PubMed ID: 23350964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
    Wu WY; Chan HY; Tan HK
    Acta Neuropsychiatr; 2014 Feb; 26(1):61-4. PubMed ID: 25142102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.
    Thone J
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865
    [No Abstract]   [Full Text] [Related]  

  • 50. Aripiprazole prescribing patterns and side effects in elderly psychiatric inpatients.
    Coley KC; Scipio TM; Ruby C; Lenze EJ; Fabian TJ
    J Psychiatr Pract; 2009 Mar; 15(2):150-3. PubMed ID: 19339850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.
    Vieta E; T'joen C; McQuade RD; Carson WH; Marcus RN; Sanchez R; Owen R; Nameche L
    Am J Psychiatry; 2008 Oct; 165(10):1316-25. PubMed ID: 18381903
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three cases of hypomania and one case of mania during aripiprazole treatment.
    Viikki M; Valtonen HM; Leinonen E
    Pharmacopsychiatry; 2011 Mar; 44(2):78-81. PubMed ID: 21157696
    [No Abstract]   [Full Text] [Related]  

  • 53. Predictors of aripiprazole treatment continuation in hospitalized patients.
    Coley KC; Fabian TJ; Kim E; Ammerman DK; Scipio TM; Saul MI; Kim MS; Whitehead R; Ganguli R
    J Clin Psychiatry; 2008 Sep; 69(9):1393-7. PubMed ID: 19012819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of the safety and tolerability of aripiprazole.
    Pae CU
    Expert Opin Drug Saf; 2009 May; 8(3):373-86. PubMed ID: 19505266
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of two fixed doses of aripiprazole with placebo in acutely relapsed, hospitalized patients with bipolar disorder I (manic or mixed) in subpopulations (CN138-007).
    El Mallakh RS; Vieta E; Rollin L; Marcus R; Carson WH; McQuade R
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):776-83. PubMed ID: 20728318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.
    Tsai AC; Rosenlicht NZ; Jureidini JN; Parry PI; Spielmans GI; Healy D
    PLoS Med; 2011 May; 8(5):e1000434. PubMed ID: 21559324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aripiprazole and neuroleptic malignant syndrome.
    Chakraborty N; Johnston T
    Int Clin Psychopharmacol; 2004 Nov; 19(6):351-3. PubMed ID: 15486522
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aripiprazole: new drug. Just another neuroleptic.
    Prescrire Int; 2005 Oct; 14(79):163-7. PubMed ID: 16285069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance.
    de Bartolomeis A; Perugi G
    Expert Opin Pharmacother; 2012 Oct; 13(14):2027-36. PubMed ID: 22946707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aripiprazole monotherapy in the treatment of bipolar disorder: a meta-analysis.
    Fountoulakis KN; Vieta E; Schmidt F
    J Affect Disord; 2011 Oct; 133(3):361-70. PubMed ID: 21040979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.